PharmaBoardroom

China: Emerging Pharmacovigilance Framework Ensuring Safe…

PPC China’s Sophia Duan, writing in the January edition of DIA’s Global Forum magazine, details how the emergence of an effective…

China Pharma News: 61.7% Profit Hit Needed for NDRL Listing;…

Some of the biggest stories across China’s healthcare and life science industry today, including the 61.7 percent average price reduction Big Pharma…

PharmaBoardroom’s Top Five Op-Eds of 2021

PharmaBoardroom's network of thought leaders provided some of our best-read content in 2021 on topics ranging from China's National Reimbursement Drug…

Top 10 Global Pharma Markets Ranking

Based on IQVIA’s pharma market rankings for 2020, we give a rundown of the global top 10, key companies, important trends, and where you can go to…

China Pharma News: 61.7% Price Cuts in New NRDL; WHO Asks Chinese…

The latest news from Chinese pharma, including an examination of the new national reimbursement drug list (NRDL), the therapies that have and have not…

Abogen: Billion Dollar 2021 for China’s Thermostable mRNA Hope

The phenomenal success of the Pfizer/BioNTech and Moderna COVID-19 vaccines has catapulted messenger RNA (mRNA) vaccines into public consciousness,…

Hong Kong: HKEX Continues Biotech Momentum in Q3 2021

Despite a “turbulent macro backdrop,” the strong momentum in Hong Kong’s IPO market has continued in the third quarter of 2021, driven to a…

BeiGene’s John Oyler on Five Key China Pharma Trends

Perhaps Chinese biotech’s biggest success story, cancer-focused Beigene has evolved from the commitment of founders John Oyler and Xiaodong Wang to…

Bruno Delie – General Manager, Luye Pharma Switzerland

Luye Pharma is a China-headquartered fully integrated oncology and CNS specialist. Bruno Delie, general manager for Switzerland, discusses the…

New Leadership for Novartis Oncology China

Portuguese national Isabel Afonso, a Novartis and Sandoz veteran of almost 20 years, has taken on a new role as general manager of Novartis’ highly…

China Pharma News: Accelerated Approvals Down; Pfizer Drone Show;…

The latest news from Chinese pharma, including a new report showing that despite the increasing number of Priority Review and Breakthrough Therapy…

China Pharma News: BMS/BeiGene Spat Intensifies; US Senators Call…

The latest news from Chinese pharma and biotech, including BMS’ attempts to pull out of its Abraxane supply deal with local player BeiGene; a…

Tagged with China